UE9-22779-56375 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-26
Dose 1 — Janssen/Johnson & Johnson
2021-07-27
Registered in v-safe
2021-07-27
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Nausea, Abdominal pain · Be unable to work or attend school

Adult check-in
2021-07-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-08-05
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-08-12
Survey response — day 14, dose 1
MedDRA: Headache — Feeling: Fair

Free text: Headache

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-26
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-09-07
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-10-25
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2022-01-24
Survey response — 6 months, dose 1
MedDRA: Dysphonia, Dyspnoea, Headache — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Breathing heavier than usual. Voice changed, headaches.

MedDRA releases: 2024-11 · check-in free text available
2022-01-24
Report sent to call center — 6 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-01-25
Call 1 — Left Voicemail
2022-07-26
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-26	Janssen/Johnson & Johnson	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — day 14, dose 1

2021-08-12

Symptoms: Headache

Release 11 — 6 months, dose 1

2022-01-24

Symptoms: Breathing heavier than usual. Voice changed, headaches.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dysphonia	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Headache	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release